Serum sclerostin as a biomarker of disease activity in ankylosing spondylitis in correlation with radiographic imaging
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Serum sclerostin as a biomarker of disease activity in ankylosing spondylitis in correlation with radiographic imaging ; volume:51 ; number:1 ; day:23 ; month:5 ; year:2024 ; pages:1-6 ; date:12.2024
Egyptian rheumatology & rehabilitation ; 51, Heft 1 (23.5.2024), 1-6, 12.2024
- Urheber
-
Sakrana, Nouran Medhat Abd El Samad
Badr, Nevine Mohamed ElSayed
Hassan, Manar Ahmed Azab
Hassan, Marwa Ahmed Kamel
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s43166-024-00258-5
- URN
-
urn:nbn:de:101:1-2408021003587.522621103530
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Sakrana, Nouran Medhat Abd El Samad
- Badr, Nevine Mohamed ElSayed
- Hassan, Manar Ahmed Azab
- Hassan, Marwa Ahmed Kamel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Relationship between smoking, clinical, inflammatory, and radiographic parameters in patients with ankylosing spondylitis
Andersson lesion in ankylosing spondylitis
Association between changes in serum alkaline phosphatase levels and radiographic progression in ankylosing spondylitis
Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker
Cross-walk of the Assessment of Spondyloarthritis International Society Health Index and Ankylosing Spondylitis Quality of Life Scores in Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Patients
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
Incorporating assessment of the cervical facet joints in the modified Stoke ankylosing spondylitis spine score is of additional value in the evaluation of spinal radiographic outcome in ankylosing spondylitis
Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Relationship between smoking, clinical, inflammatory, and radiographic parameters in patients with ankylosing spondylitis
Andersson lesion in ankylosing spondylitis
Association between changes in serum alkaline phosphatase levels and radiographic progression in ankylosing spondylitis
Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker
Cross-walk of the Assessment of Spondyloarthritis International Society Health Index and Ankylosing Spondylitis Quality of Life Scores in Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Patients
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
Incorporating assessment of the cervical facet joints in the modified Stoke ankylosing spondylitis spine score is of additional value in the evaluation of spinal radiographic outcome in ankylosing spondylitis
Hepatocyte growth factor is a potential biomarker for osteoproliferation and osteoporosis in ankylosing spondylitis
Scoring radiographic progression in ankylosing spondylitis: should we use the modified Stoke Ankylosing Spondylitis Spine Score (mSASSS) or the Radiographic Ankylosing Spondylitis Spinal Score (RASSS)?
Relationship between smoking, clinical, inflammatory, and radiographic parameters in patients with ankylosing spondylitis
Andersson lesion in ankylosing spondylitis
Association between changes in serum alkaline phosphatase levels and radiographic progression in ankylosing spondylitis
Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?
Anti-SIRT1 autoantibody is elevated in ankylosing spondylitis: a potential disease biomarker
Cross-walk of the Assessment of Spondyloarthritis International Society Health Index and Ankylosing Spondylitis Quality of Life Scores in Ankylosing Spondylitis and Non-radiographic Axial Spondyloarthritis Patients
Surgical treatment of ankylosing spondylitis deformity
Secukinumab: A Review in Ankylosing Spondylitis
Is the exposure to bisphosphonates or osteoporosis the predictor of spinal radiographic progression in ankylosing spondylitis?
Incorporating assessment of the cervical facet joints in the modified Stoke ankylosing spondylitis spine score is of additional value in the evaluation of spinal radiographic outcome in ankylosing spondylitis